Enliven Therapeutics Inc ELVNNasdaq
58.78USDClose on 08/11
At a glance
Enliven Therapeutics Inc sits in the ‘Just starting’ stage of its cycle. It has moved -1.1% since its first surge signal on 2026-08-10, when the past-year gain stood at +232.0%.
- Since surge signal
- -1.1%
- First surge signal
- 2026-08-10
- Price at signal
- 59.42
- Past-year gain (at signal)
- +232.0%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-11
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.